|
Secondary prevention
Citations 31-40 of 240 total displayed.
|
Past content
(since Jun 2001):
|
- Go Red for Women
Quality of Care in Women With Ischemic Stroke in the GWTG Program
- Mathew J. Reeves, Gregg C. Fonarow, Xin Zhao, Eric E. Smith, Lee H. Schwamm on behalf of the GWTG-Stroke Steering Committee & Investigators
Stroke 2009;40:1127-1133; published online before print as doi:10.1161/STROKEAHA.108.543157
[Abstract]
[Full text]
- Go Red for Women
Does Sex Matter? Thirty-Day Stroke and Death Rates After Carotid Artery Stenting in Women Versus Men: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) Lead-in Phase
- Virginia J. Howard, Jenifer H. Voeks, Helmi L. Lutsep, Ariane Mackey, Genevieve Milot, Albert D. Sam, II, MeeLee Tom, Susan E. Hughes, Alice J. Sheffet, Mary Longbottom, Jason B. Avery, Robert W. Hobson, II, and Thomas G. Brott
Stroke 2009;40:1140-1147; published online before print as doi:10.1161/STROKEAHA.108.541847
[Abstract]
[Full text]
- Original Contributions
Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability: Additional Findings From the HOPE 2 Trial
- Gustavo Saposnik, Joel G. Ray, Patrick Sheridan, Matthew McQueen, Eva Lonn, and the HOPE 2 Investigators
Stroke 2009;40:1365-1372; published online before print as doi:10.1161/STROKEAHA.108.529503
[Abstract]
[Full text]
- Original Contributions
Applying the Evidence: Do Patients With Stroke, Coronary Artery Disease, or Both Achieve Similar Treatment Goals?
- Gustavo Saposnik, Shaun G. Goodman, Lawrence A. Leiter, Raymond T. Yan, David H. Fitchett, Neville H. Bayer, Amparo Casanova, Anatoly Langer, Andrew T. Yan, for the Vascular Protection (VP), Guidelines-Oriented Approach to Lipid-Lowering (GOALL) Registries Investigators on behalf of the Stroke Outcome Research Canada (SORCan) Working Group
Stroke 2009;40:1417-1424; published online before print as doi:10.1161/STROKEAHA.108.533018
[Abstract]
[Full text]
- Original Contributions
Postpublication External Review of the Japanese Guidelines for the Management of Stroke 2004
- Yukito Shinohara, Masao Nagayama, and Hideki Origasa
Stroke 2009;40:1439-1443; published online before print as doi:10.1161/STROKEAHA.108.535070
[Abstract]
[Full text]
- Articles
Placebo-Controlled Trial of High-Dose Atorvastatin in Patients With Severe Cerebral Small Vessel Disease
- Philippa C. Lavallée, Julien Labreuche, Fernando Gongora-Rivera, Arturo Jaramillo, David Brenner, Isabelle F Klein, Pierre-Jean Touboul, Eric Vicaut, Pierre Amarenco on behalf of the Lacunar-B.I.C.H.A.T. Investigators
Stroke published March 12, 2009, doi:10.1161/STROKEAHA.108.540088
[Abstract]
- Articles
Use of Stroke Secondary Prevention Services. Are There Disparities in Care?
- Joseph S. Ross, Ethan A. Halm, and Dawn M. Bravata
Stroke published March 5, 2009, doi:10.1161/STROKEAHA.108.539619
[Abstract]
- Original Contributions
Sex Differences in Stroke Care and Outcome in the Swedish National Quality Register for Stroke Care
- Marie Eriksson, Eva-Lotta Glader, Bo Norrving, Andreas Terént, and Birgitta Stegmayr
Stroke 2009;40:909-914; published online before print as doi:10.1161/STROKEAHA.108.517581
[Abstract]
[Full text]
- Articles
Postpublication External Review of the Japanese Guidelines for the Management of Stroke 2004
- Yukito Shinohara, Masao Nagayama, and Hideki Origasa
Stroke published February 19, 2009, doi:10.1161/STROKEAHA.108.535070
[Abstract]
- Articles
Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability. Additional Findings From the HOPE 2 Trial
- Gustavo Saposnik, Joel G. Ray, Patrick Sheridan, Matthew McQueen, Eva Lonn the HOPE 2 Investigators
Stroke published February 19, 2009, doi:10.1161/STROKEAHA.108.529503
[Abstract]
|
|
